(Q48656998)

14 February 2018

title

Effects of ketamine on brain function during smooth pursuit eye movements (English)

1 reference

14 February 2018

author

Benjamin Becker

2

1 reference

14 February 2018

Rene Hurlemann

8

1 reference

14 February 2018

Ulrich Ettinger

object named as

U Ettinger

9

0 references

author name string

M Steffens

1

1 reference

14 February 2018

C Neumann

3

1 reference

14 February 2018

A M Kasparbauer

4

1 reference

14 February 2018

I Meyhöfer

5

1 reference

14 February 2018

B Weber

6

1 reference

14 February 2018

M A Mehta

7

1 reference

14 February 2018

publication date

25 June 2016

1 reference

14 February 2018

number of pages

14

0 references

published in

Human Brain Mapping

1 reference

14 February 2018

volume

37

1 reference

14 February 2018

issue

11

1 reference

14 February 2018

page(s)

4047-4060

1 reference

14 February 2018

The NMDA antagonist model for schizophrenia: promise and pitfalls.

cites work

1 reference

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate

21 January 2018

1 reference

Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia

21 January 2018

1 reference

Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac?

21 January 2018

1 reference

Early-stage visual processing deficits in schizophrenia

21 January 2018

1 reference

Brain activation induced by psychological stress in patients with schizophrenia.

21 January 2018

1 reference

Metabotropic glutamate receptors: potential drug targets for the treatment of schizophrenia

21 January 2018

1 reference

Compromised late-stage motion processing in schizophrenia.

21 January 2018

1 reference

21 January 2018

1 reference

From prediction error to psychosis: ketamine as a pharmacological model of delusions.

21 January 2018

1 reference

Visual motion and the human brain: what has neuroimaging told us?

21 January 2018

1 reference

Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis

21 January 2018

1 reference

Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers

21 January 2018

1 reference

Functional magnetic resonance imaging activations of cortical eye fields during saccades, smooth pursuit, and optokinetic nystagmus.

21 January 2018

1 reference

Quantifying the attenuation of the ketamine pharmacological magnetic resonance imaging response in humans: a validation using antipsychotic and glutamatergic agents.

21 January 2018

1 reference

The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity

21 January 2018

1 reference

A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data

21 January 2018

1 reference

Smooth pursuit and antisaccade eye movements in siblings discordant for schizophrenia

21 January 2018

1 reference

Statistical parametric maps in functional imaging: A general linear approach

21 January 2018

1 reference

Reviewing the ketamine model for schizophrenia

21 January 2018

1 reference

Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study

21 January 2018

1 reference

Smooth pursuit eye tracking and visual fixation in psychosis-prone individuals

21 January 2018

1 reference

Acute ketamine challenge increases resting state prefrontal-hippocampal connectivity in both humans and rats

21 January 2018

1 reference

Eye movement deficits in schizophrenia: investigation of a genetically homogenous Icelandic sample

21 January 2018

1 reference

Eye-Tracking Patterns in Schizophrenia

21 January 2018

1 reference

Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: an FMRI study.

21 January 2018

1 reference

Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: an fMRI study

21 January 2018

1 reference

Specific motion processing pathway deficit during eye tracking in schizophrenia: a performance-matched functional magnetic resonance imaging study

21 January 2018

1 reference

Oculomotor abnormalities in schizophrenia: a critical review

21 January 2018

1 reference

Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia

21 January 2018

1 reference

Ketamine induces a robust whole-brain connectivity pattern that can be differentially modulated by drugs of different mechanism and clinical profile

21 January 2018

1 reference

Thinking Glutamatergically: Changing Concepts of Schizophrenia Based Upon Changing Neurochemical Models

21 January 2018

1 reference

Functional magnetic resonance imaging studies of eye movements in first episode schizophrenia: smooth pursuit, visually guided saccades and the oculomotor delayed response task.

21 January 2018

1 reference

A hundred years of eye movement research in psychiatry

21 January 2018

1 reference

Evaluation of state and trait biomarkers in healthy volunteers for the development of novel drug treatments in schizophrenia.

21 January 2018

1 reference

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

21 January 2018

1 reference

Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function

21 January 2018

1 reference

Effects of ketamine in normal and schizophrenic volunteers

21 January 2018

1 reference

Syndromes of schizophrenia and smooth-pursuit eye movement dysfunction

21 January 2018

1 reference

Altered transfer of visual motion information to parietal association cortex in untreated first-episode psychosis: implications for pursuit eye tracking.

21 January 2018

1 reference

Neurophysiology and neuroanatomy of smooth pursuit in humans

21 January 2018

1 reference

Smooth pursuit performance in families with multiple occurrence of schizophrenia and nonpsychotic families

21 January 2018

1 reference

Smooth pursuit deficits in schizophrenia, affective disorder and obsessive-compulsive disorder

21 January 2018

1 reference

Reduced neuronal activity in the V5 complex underlies smooth-pursuit deficit in schizophrenia: evidence from an fMRI study.

21 January 2018

1 reference

Smooth pursuit eye movement and schizotypy in the community

21 January 2018

1 reference

Eye tracking dysfunction and schizophrenia: a critical perspective

21 January 2018

1 reference

Eye tracking dysfunction in schizophrenia: characterization and pathophysiology

21 January 2018

1 reference

Behavioral effects of orally administered glycine in socially housed monkeys chronically treated with phencyclidine

21 January 2018

1 reference

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

21 January 2018

1 reference

The psychotomimetic states inventory (PSI): measuring psychotic-type experiences from ketamine and cannabis.

21 January 2018

1 reference

Neural mechanisms of smooth pursuit eye movements in schizotypy

21 January 2018

1 reference

What can we learn about schizophrenia from studying the human model, drug-induced psychosis?

21 January 2018

1 reference

Cortical mechanisms of retinal and extraretinal smooth pursuit eye movements to different target velocities.

21 January 2018

1 reference

Altered velocity processing in schizophrenia during pursuit eye tracking

21 January 2018

1 reference

Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency

21 January 2018

1 reference

Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency

21 January 2018

1 reference

Brain connectivity studies in schizophrenia: unravelling the effects of antipsychotics

21 January 2018

1 reference

What are the neurocognitive correlates of basic self-disturbance in schizophrenia? Integrating phenomenology and neurocognition: Part 2 (aberrant salience).

21 January 2018

1 reference

Effect of subanesthetic ketamine on intrinsic functional brain connectivity: a placebo-controlled functional magnetic resonance imaging study in healthy male volunteers

21 January 2018

1 reference

Neural correlates of eye tracking deficits in first-degree relatives of schizophrenic patients: a positron emission tomography study

21 January 2018

1 reference

Smooth pursuit in schizophrenia: a meta-analytic review of research since 1993.

21 January 2018

1 reference

Phenomenologically distinct psychotomimetic effects of ketamine are associated with cerebral blood flow changes in functionally relevant cerebral foci: a continuous arterial spin labelling study

21 January 2018

1 reference

Psychological effects of ketamine in healthy volunteers. Phenomenological study

21 January 2018

1 reference

Does ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities?

21 January 2018

1 reference

Anticipatory saccades during smooth pursuit eye movements and familial transmission of schizophrenia

21 January 2018

1 reference

The effects of ketamine and risperidone on eye movement control in healthy volunteers

21 January 2018

1 reference

Metric issues in the study of eye movements in psychiatry

21 January 2018

1 reference

Smooth pursuit eye movements in 1,087 men: effects of schizotypy, anxiety, and depression

21 January 2018

1 reference

Drug models of schizophrenia

21 January 2018

1 reference

Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia?

21 January 2018

1 reference

Review: The biological basis of antipsychotic response in schizophrenia

21 January 2018

1 reference

Neuropsychological and Eye Movement Abnormalities in First-episode and Chronic Schizophrenia

21 January 2018

1 reference

Neurobiology of smooth pursuit eye movement deficits in schizophrenia: an fMRI study

21 January 2018

1 reference

Network dysfunction during associative learning in schizophrenia: Increased activation, but decreased connectivity: an fMRI study.

21 January 2018

1 reference

Ketamine effects on eye movements

21 January 2018

1 reference

Disruption of prefrontal cortex large scale neuronal activity by different classes of psychotomimetic drugs

21 January 2018

1 reference

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex

21 January 2018

1 reference

7 January 2021

Different extraretinal neuronal mechanisms of smooth pursuit eye movements in schizophrenia: An fMRI study

1 reference

7 January 2021

Dissociation of saccade-related and pursuit-related activation in human frontal eye fields as revealed by fMRI.

1 reference

7 January 2021

Biological markers in schizotypal personality disorder

1 reference

7 January 2021

Functional analysis of V3A and related areas in human visual cortex

1 reference

7 January 2021

Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans

1 reference

12 December 2020

Imaging glutamate in schizophrenia: review of findings and implications for drug discovery

1 reference

12 December 2020

Ketamine: teaching an old drug new tricks

1 reference

12 December 2020

Schizophrenia spectrum disorders and eye tracking dysfunction in singleton and multiplex schizophrenia families

1 reference

12 December 2020

Ketamine-induced disruption of verbal self-monitoring linked to superior temporal activation

1 reference

12 December 2020

Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay

1 reference

12 December 2020

Identifiers

DOI

10.1002/HBM.23294

1 reference

14 February 2018

1 reference

14 February 2018